This week, a number of companies, big and small, shared updates on their cardiovascular technology innovations at EuroPCR ...

Elixir Medical announced three-year results from a large randomized controlled trial of its DynamX coronary bioadaptor system ...

Explore the global vascular grafts market's trends, forecasts, and growth led by aortic, peripheral, AAA, and TAA stent grafts. Regions include North America, Europe, APAC, LATAM, and MEA. Key players ...

Three-year data from Elixir Medical Corp.’s Bioadaptor randomized controlled trial showed that patients with coronary artery ...

but no increase in cardiovascular events. The FDA documents suggest that in one of pivotal studies of the new stent (Endeavor IV), 0.8% of patients who received Medtronic’s stent suffered a thrombosis ...

The study will compare Medtronic's Endeavor zotarolimus-eluting coronary stent system, which is available in more than 100 countries and is being reviewed by the U.S. Food and Drug Administration ...

Medtronic is one of four or five companies that manufacture stent-grafts for the treatment ... according to the Society for Vascular Surgery, a physician group. The aneurysms are most frequently ...

ISR occurs when a stent is placed in the artery to restore ... which is part of the Aortic & Peripheral Vascular division at Medtronic. "Together, in collaboration with physicians in the vascular ...

Endovascular stent grafts offer a catheter-based ... the device leverages skill sets that are quite routine for vascular surgeons." Medtronic claims that almost half of all endovascular aortic ...